Documents that deepen how continuous patient-journey intelligence changes decisions for Commercial, Market Access and Medical. Access granted with a quick registration.
White Paper
From market snapshot to continuous intelligence
Why oncology decisions require recurring visibility into the real patient journey — and how to tell eligibility, testing, access and physician-preference problems apart before they show up in late data.
Format PDFRead time ~12 minLanguage PT-BR
Executive Introduction
maviePulse™ — From clinical reality to executive decision
A one-page executive view of maviePulse's four intelligence engines and the business questions the platform answers. Ideal to bring to a first internal conversation.
Format PDFRead time ~5 minLanguage PT-BR
Checklist
The 4 questions your current evidence still can't answer
A short diagnostic for pharma teams to spot visibility gaps in the patient journey — the basis of the IPE™.
Format PDFRead time ~3 min
Coming soonCase study
Urothelial carcinoma: reading the journey in 1L and 2L
How continuous reading of therapeutic sequencing and biomarkers reveals drop-off points between diagnosis and the next line.
Format PDFRead time ~8 min
Coming soon
Governance note: the materials shared here are public versions. Real project data is handled under confidentiality and does not appear in an open environment.